急性脑梗死患者发生阿司匹林抵抗相关危险因素分析
Analysis of Risk Factors Related to Aspirin Resistance in Patients with Acute Cerebral Infarction
摘要: 目的:探讨急性脑梗死患者发生阿司匹林抵抗与相关危险因素的关系。方法:潍坊益都市中心医院2022年10月至2023年5月急性脑梗死患者共358名,患者于入院当日开始口服阿司匹林肠溶片100 mg/d,服用阿司匹林10 d后,根据血小板聚集实验结果将患者分为阿司匹林抵抗(Aspirin Resistance, AR)组和阿司匹林敏感(Aspirin sensitivity, AS)组,分别就AR组和AS组的血小板内皮聚集受体1 (Platelet-endothelial aggregation receptor 1, PEAR1)基因型的分布情况、高血压、2型糖尿病、性别、年龄、吸烟、饮酒等数据进行收集。结果:与AS组患者比较,AR组患者在性别、高血压、2型糖尿病、吸烟史等方面差异有统计学意义(P < 0.05);而年龄、饮酒史方面比较,差异无统计学意义(P > 0.05);AR组PEAR1野生型GG基因频率低于AS组,差异有统计学意义(P < 0.05);AR组PEAR1纯合突变型AA基因频率高于AS组,差异有统计学意义(P < 0.05)。结论:急性脑梗死患者发生阿司匹林抵抗与患者PEAR1基因的多态性、高血压、2型糖尿病、性别和吸烟等因素有关。
Abstract:
Objective: To investigate the relationship between aspirin resistance and related risk factors in pa-tients with acute cerebral infarction. Methods: A total of 358 patients with acute cerebral infarction were diagnosed in Weifang Yidu Central Hospital from October 2022 to May 2023. The patients be-gan to take aspirin enteric-coated tablets 100 mg/d orally on the day of admission, and after taking aspirin for 10 days, according to the platelet aggregation test results, the patients were divided into Aspirin Resistance (AR) group and Aspirin Sensitivity (AS) group. Platelet aggregation receptor 1 (PEAR1) genotype distribution, hypertension, type 2 diabetes, gender, age, smoking, alcohol con-sumption and other data were collected in AR and AS groups. Results: Compared with AS group, AR group had significant differences in gender, hypertension, type 2 diabetes, smoking history and other aspects (P < 0.05). There was no significant difference in age and drinking history (P > 0.05). The frequency of PEAR1 wild type GG gene in AR group was lower than that in AS group, and the difference was statistically significant (P < 0.05); the frequency of PEAR1 homozygous mutant AA gene in AR group was higher than that in AS group, the difference was statistically significant (P < 0.05). Conclusion: The occurrence of aspirin resistance in patients with acute cerebral infarction is related to PEAR1 gene polymorphism, hypertension, type 2 diabetes, sex and smoking.
参考文献
|
[1]
|
赵佳驹, 吴波. 社区缺血性卒中的二级预防[J]. 中国卒中杂志, 2018, 13(6): 591-593.
|
|
[2]
|
Johnston, S.C., Easton, J.D., et al. (2018) Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. The New England Journal of Medicine, 379, 215-225. [Google Scholar] [CrossRef]
|
|
[3]
|
张鹙月, 刘玉锦, 张敏. 缺血性脑卒中阿司匹林抵抗危险因素的Meta分析[J]. 心脑血管病防治, 2022, 22(6): 32-37+50.
|
|
[4]
|
刘岩, 李丽琼, 曲颖, 刘艳霞. 血小板内皮聚集受体1基因多态性与阿司匹林抵抗及心血管事件发生相关性研究[J]. 临床军医杂志, 2021, 49(5): 532-535.
|
|
[5]
|
Snoep, J.D., et al. (2007) Association of Laboratory-Defined Aspirin Resistance with a Higher Risk of Recurrent Cardiovascular Events: A Systematic Review and Meta-Analysis. Archives Internal Medicine, 167, 1593-1599. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Krasopoulos, G., et al. (2008) Aspirin “Resistance” and Risk of Cardiovascular Morbidity: Systematic Review and Meta-Analysis. BMJ, 336, 195-198. [Google Scholar] [CrossRef]
|
|
[7]
|
周玉玲, 高彩红, 严进华, 孙伟璐, 张维国. 阿司匹林抵抗与基因多态性关系研究进展[J]. 中风与神经疾病杂志, 2021, 38(8): 766-768.
|
|
[8]
|
Izzi, B., Gianfagna, F., et al. (2019) Variation of PEAR1 DNA Methylation Influences Platelet and Leukocyte Function. Clinical Epigenetics, 11, Ar-ticle No. 151. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Xiang, Q., Zhou, S., et al. (2017) Genetic Variants of PEAR1 Are Associated with Platelet Function and Antiplatelet Drug Efficacy: A Systematic Review and Me-ta-Analysis. Current Pharmaceutical Design, 23, 6815-6827. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Nie, X.-Y., Li. J.-L., et al. (2018) Genetic Mutations in PEAR1 Associated with Cardiovascular Outcomes in Chinese Patients with Acute Coronary Syndrome. Thrombosis Research, 163, 77-82. [Google Scholar] [CrossRef] [PubMed]
|